Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT03829566 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03829566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Lead sponsor
Northwestern University
Phase
Phase 2/3
Overall status
Withdrawn
Start date
November 30, 2019
Completion date
November 28, 2025
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

devic's disease, neuromyelitis optica, nmo spectrum disorder